France· FR:66324953
CLOPIDOGREL ARROW 75 mg, comprimé pelliculé
A clopidogrel product containing hydrogénosulfate de clopidogrel, registered in France by ARROW GENERIQUES, on the reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Clopidogrel is registered in 17 of 19 countries.
Countries holding a registration under ATC B01AC04 (clopidogrel), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Clopidogrel · ATC B01AC04
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clopidogrel costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.15 in Czechia to $1.20 in Norway — a ×8.2 gap.
- France: $0.29 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Clopidogrel · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- NO Norway$1.20
- CH Switzerland$1.04
- IT Italy$0.48
- FI Finland$0.43
- IS Iceland$0.42
- FR France$0.29
- CZ Czechia$0.15
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- HYDROGÉNOSULFATE DE CLOPIDOGREL
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- B01AC04
- ATC class
- Clopidogrel
- Defined daily dose
- 75 mg, O
- Dispensing
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400927396083plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)EUR 7.75
- cip1334009273972641 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)EUR 7.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
61 interactions on record for clopidogrel.
Graded by severity as the source publishes them — 27 severe. The interaction check adds the mechanism and what to do for each pair.
- Severity, mechanism and recommendation for each pair
- The source and sync date on every record
- Screen a whole medication list at once — Growth plan
Clopidogrel · interactions on record
61 records
- 27 severe
- 24 moderate
- 9 minor
- 1 info
Most severe on record
- PiroxicamM01AC01severe
- DiclofenacM01AB05severe
- Ibuprofen, KombinationenM01AE51severe
- NaproxenM01AE02severe
Same class
Other records under B01AC04
Clopidogrel, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9f4a2467-5393-47ca-8e2a-8927af35ae43 GET /v1/drugs/9f4a2467-5393-47ca-8e2a-8927af35ae43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66324953",
"date_amm": "2016-12-02",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "HYDROGÉNOSULFATE DE CLOPIDOGREL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about clopidogrel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction checking is on the Growth plan. No card, nothing to install.